Price movement over the last 24 hours
ARK Genomic Revolution ETF vs iShares MSCI Japan ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while iShares MSCI Japan ETF trades at $92.98. Which is the better fit depends on your goals.
| ARKG | EWJ | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $96.97 |
52-Week Low | $23.09 | $71.69 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EWJ, the iShares MSCI Japan ETF, trades at $94.55, up 1.1% today, with a bullish technical signal from moving averages. The fund tracks Japanese equities, facing currency headwinds as the yen weakens against the dollar. Recent news highlights potential FX intervention by Japanese authorities to support the yen, which could impact returns for USD-based investors. Technical indicators show support at $92 and resistance at $95, with neutral oscillators suggesting limited momentum.
The outlook for EWJ is mixed, with opportunities from Japan's domestic investment push and AI-driven stock gains, but risks include yen volatility and economic sensitivity. Investors should weigh currency-hedged options to mitigate FX drag, as structural reforms and pension fund shifts may offer long-term growth amid near-term uncertainty.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →